Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
41,008,925
-
Share change
-
-1,858,325
-
Total reported value
-
$101,698,321
-
Price per share
-
$2.48
-
Number of holders
-
61
-
Value change
-
-$4,079,285
-
Number of buys
-
34
-
Number of sells
-
22
Institutional Holders of TRANSENTERIX INC - COM NEW (TRXC) as of Q4 2015
As of 31 Dec 2015,
TRANSENTERIX INC - COM NEW (TRXC) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,008,925 shares.
The largest 10 holders included
Aisling Capital LLC, SV Life Sciences Advisers, LLC, MASTERS CAPITAL MANAGEMENT LLC, JPMORGAN CHASE & CO, StepStone Group LP, PERCEPTIVE ADVISORS LLC, SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock Fund Advisors, and GOLDMAN SACHS GROUP INC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.